Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Huffman

Showing results (211-220 of 325) with videos related to

Pageof 33
Sort By:
Eclinicalmedicine|June 6, 2024
Cost effectiveness analysis of a fixed dose combination pill for primary prevention of cardiovascular disease from an individual participant data meta-analysisAndre Lamy, Wesley Tong, Philip Joseph, et al.
Global Heart|June 19, 2023
Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional AnalysisAishwarya Vijay, Wan Ting Tay, Tiew-Hwa K Teng, et al.
Nutrients|February 11, 2023
Presence of <i>trans</i>-Fatty Acids Containing Ingredients in Pre-Packaged Foods and the Availability of Reported <i>trans</i>-Fat Levels in Kenya and NigeriaLiping Huang, Adedayo E Ojo, Judith Kimiywe, et al.
Global Heart|February 19, 2015
Trans-Disciplinary Education and Training for NCD Prevention and ControlKaren R Siegel, Sandeep P Kishore, Mark D Huffman, et al.
Nature Medicine|June 17, 2024
Author Correction: Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseaseAnubha Agarwal, Priya M Mehta, Tyler Jacobson, et al.
Implementation Science Communications|August 31, 2021
Stakeholder perspectives to inform adaptation of a hypertension treatment program in primary healthcare centers in the Federal Capital Territory, Nigeria: a qualitative studyRosemary C B Okoli, Gabriel Shedul, Lisa R Hirschhorn, et al.
Nature Medicine|March 27, 2024
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseaseAnubha Agarwal, Priya M Mehta, Tyler Jacobson, et al.
International Journal of Cardiology|October 13, 2020
Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registrySivadasanpillai Harikrishnan, Panniyammakal Jeemon, Sanjay Ganapathi, et al.
Journal of Cardiac Failure|May 28, 2021
Distribution and Correlates of Incident Heart Failure Risk in South Asian Americans: The MASALA StudyNilay S Shah, Anubha Agarwal, Mark D Huffman, et al.
Journal of the American Heart Association|December 29, 2023
Process Evaluation of a Double-Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-Low-Dose Treatment for Hypertension Within a Federally Qualified Health Center Network (QUARTET USA)Olutobi A Sanuade, Tyler A Jacobson, Adriana Quintana, et al.
Pageof 33

Showing results (211-220 of 325) with videos related to

Sort By:
Pageof 33
Eclinicalmedicine|June 6, 2024
Cost effectiveness analysis of a fixed dose combination pill for primary prevention of cardiovascular disease from an individual participant data meta-analysisAndre Lamy, Wesley Tong, Philip Joseph, et al.
Global Heart|June 19, 2023
Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional AnalysisAishwarya Vijay, Wan Ting Tay, Tiew-Hwa K Teng, et al.
Nutrients|February 11, 2023
Presence of <i>trans</i>-Fatty Acids Containing Ingredients in Pre-Packaged Foods and the Availability of Reported <i>trans</i>-Fat Levels in Kenya and NigeriaLiping Huang, Adedayo E Ojo, Judith Kimiywe, et al.
Global Heart|February 19, 2015
Trans-Disciplinary Education and Training for NCD Prevention and ControlKaren R Siegel, Sandeep P Kishore, Mark D Huffman, et al.
Nature Medicine|June 17, 2024
Author Correction: Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseaseAnubha Agarwal, Priya M Mehta, Tyler Jacobson, et al.
Implementation Science Communications|August 31, 2021
Stakeholder perspectives to inform adaptation of a hypertension treatment program in primary healthcare centers in the Federal Capital Territory, Nigeria: a qualitative studyRosemary C B Okoli, Gabriel Shedul, Lisa R Hirschhorn, et al.
Nature Medicine|March 27, 2024
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseaseAnubha Agarwal, Priya M Mehta, Tyler Jacobson, et al.
International Journal of Cardiology|October 13, 2020
Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registrySivadasanpillai Harikrishnan, Panniyammakal Jeemon, Sanjay Ganapathi, et al.
Journal of Cardiac Failure|May 28, 2021
Distribution and Correlates of Incident Heart Failure Risk in South Asian Americans: The MASALA StudyNilay S Shah, Anubha Agarwal, Mark D Huffman, et al.
Journal of the American Heart Association|December 29, 2023
Process Evaluation of a Double-Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-Low-Dose Treatment for Hypertension Within a Federally Qualified Health Center Network (QUARTET USA)Olutobi A Sanuade, Tyler A Jacobson, Adriana Quintana, et al.
Pageof 33